​

biote (BTMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BTMD Stock Forecast

biote (BTMD) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $8.62, with a high of $9.00 and a low of $8.24. This represents a 214.60% increase from the last price of $2.74.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $9 Avg: $8.62 Low: $8.24 Last Closed Price: $2.74

BTMD Stock Rating

biote stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

BTMD Price Target Upside V Benchmarks

TypeNameUpside
Stockbiote214.60%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks12.74%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.74$2.74$2.74
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-41--5
Sep, 25-41--5
Aug, 2514---5
Jul, 2514---5
Jun, 2514---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 21, 2024Gregory FraserTruist Financial$9.00$7.2324.48%228.47%
Mar 13, 2024Kaumil GajrawalaJefferies$8.24$6.0935.30%200.73%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 07, 2025B. RileyNeutraldowngrade
Nov 14, 2024Cowen & Co.BuyBuyhold
Aug 16, 2024Cowen & Co.BuyBuyhold
Jun 24, 2022Cowen & Co.Outperforminitialise

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.16$0.13$0.09---
Avg Forecast$1.71$-0.04$0.23$0.64$0.93$1.18
High Forecast$1.81$-0.04$0.25$0.79$0.98$1.26
Low Forecast$1.64$-0.04$0.20$0.56$0.88$1.12
Surprise %-90.64%-425.00%-60.87%---

Revenue Forecast

$150M $200M $250M $300M $350M $400M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$164.96M$185.36M$197.19M---
Avg Forecast$164.30M$185.47M$198.56M$226.16M$259.00M$341.94M
High Forecast$171.33M$186.31M$199.67M$237.05M$259.00M$350.16M
Low Forecast$159.32M$185.01M$197.38M$217.01M$259.00M$333.72M
Surprise %0.40%-0.06%-0.69%---

Net Income Forecast

$-5M $6M $17M $28M $39M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.32M$3.32M$3.16M---
Avg Forecast$43.96M$-1.10M$5.75M$17.37M$23.91M$30.34M
High Forecast$46.41M$-1.07M$6.39M$20.42M$25.20M$32.30M
Low Forecast$42.23M$-1.14M$5.11M$14.32M$22.62M$28.80M
Surprise %-96.99%-400.70%-45.11%---

BTMD Forecast FAQ

Is biote stock a buy?

biote stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that biote is a favorable investment for most analysts.

What is biote's price target?

biote's price target, set by 7 Wall Street analysts, averages $8.62 over the next 12 months. The price target range spans from $8.24 at the low end to $9 at the high end, suggesting a potential 214.60% change from the previous closing price of $2.74.

How does biote stock forecast compare to its benchmarks?

biote's stock forecast shows a 214.60% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (12.74%).

What is the breakdown of analyst ratings for biote over the past three months?

  • October 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is biote’s EPS forecast?

biote's average annual EPS forecast for its fiscal year ending in December 2025 is $0.64, marking a 611.11% increase from the reported $0.09 in 2024. Estimates for the following years are $0.93 in 2026, and $1.18 in 2027.

What is biote’s revenue forecast?

biote's average annual revenue forecast for its fiscal year ending in December 2025 is $226.16M, reflecting a 14.69% increase from the reported $197.19M in 2024. The forecast for 2026 is $259M, and $341.94M for 2027.

What is biote’s net income forecast?

biote's net income forecast for the fiscal year ending in December 2025 stands at $17.37M, representing an 450.14% increase from the reported $3.16M in 2024. Projections indicate $23.91M in 2026, and $30.34M in 2027.